ForsLean Gets Korean FDA OK
June 18, 2009
1 Min Read
PISCATAWAY, N.J.—Sabinsa Corp. announced its ForsLean® ingredient was formally registered with the Korean FDA as a Functional Health Food Ingredient (Permission No. 2009-47). In addition, the extensive safety and toxicology data submitted in the ForsLean dossier convinced the agency to allow the ingredient to be marketed with a specific health claim: “reduces body fat” at a dosage of 500 mg. Sabinsa is now working to finalize trademark registration of ForsLean in Korea.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like